Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
about
Effects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cells.Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedbMolecular targeted approaches for treatment of pancreatic cancer.Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells.Therapeutic Potential of Steroidal Alkaloids in Cancer and Other Diseases.Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition.GLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AML.miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer.Expression of hedgehog signalling pathway in anaplastic thyroid cancer.Aberrant activation of hedgehog pathway in nasopharyngeal carcinoma.Gli3 silencing enhances cyclopamine suppressive effects on ovarian cancer.Radiation Sensitization of Basal Cell and Head and Neck Squamous Cell Carcinoma by the Hedgehog Pathway Inhibitor Vismodegib
P2860
Q33631459-E9DD80E6-9A25-43B9-B854-B5D13B3D1C18Q34537320-C860789C-4B57-4629-91C1-7FDBB4FB7520Q36174910-C93E1FAB-5A75-4A89-9E1F-7771B6F8C0D2Q37322264-221A049A-28E8-417B-94F7-15FDB297F7A5Q38395045-8C4CD671-0EB8-40B6-89CB-11635374BA29Q38761555-81AB1744-7FC1-4750-83FC-00117B7FD158Q38795323-7CB686E8-9128-4DB3-97F8-3043B834048DQ39017343-D27BA93C-B1E5-4021-B7A6-A6AE522FF60BQ39124976-AD34AF79-53A8-4E38-9B81-C83481ADC8F0Q39273503-D4BCA60B-5B28-4F33-849A-C82653F37992Q41838064-B12919E1-2221-4E58-A757-8B3E2C6EA7A6Q58710255-056DEEDC-5C4B-4E3C-BB9D-9219F08FD629
P2860
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
@en
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
@nl
type
label
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
@en
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
@nl
prefLabel
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
@en
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
@nl
P2093
P2860
P356
P1476
Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer.
@en
P2093
Andra R Frost
Hope M Amm
Martin R Johnson
Zdenek Novak
P2860
P304
P356
10.4161/CBT.10.9.13252
P577
2010-11-01T00:00:00Z